FDA Approves New Long-Acting HIV Prevention Injection
TL;DR
The FDA approved Gilead's twice-yearly HIV prevention injection, Yeztugo, which could significantly improve prevention efforts due to its convenience and high efficacy, but its impact may be hindered by potential federal funding cuts and access issues, especially among underserved populations.
- FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option CNBC
- Regulators Approve Lenacapavir for H.I.V. Prevention The New York Times
- FDA Approves “Breakthrough” HIV Drug Mother Jones
- HIV prevention drug hailed as a 'breakthrough' gets FDA approval : Goats and Soda NPR
- FDA approves powerful HIV prevention drug: What to know about Yeztugo NBC News
Want the full story? Read the original reporting
Read on CNBC